In contrast, higher levels of TSG101 transcripts correlate significantly with reduced survival in luminal type A (Logrank p = 0.017, N = 2504) and in luminal type B (Logrank p = 0.0084, N = 1425) breast cancers (Ferraiuolo et al., manuscript in preparation). This evidence concerns the gene TSG101 and breast cancer.